Medicines & Focus
Innovation Focused
on Complex Diseases
Therapeutic Areas of Focus
We are inspired by the courage and determination of individuals living with complicated and often difficult-to-treat diseases. We have a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders.
Disease Areas
Addiction
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid dependence.
Serious Mental Illness
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support people living with schizophrenia and bipolar I disorder.
Sleep Disorders
We are actively researching potential new treatment options for people living with narcolepsy and other sleep disorders, which impair regulation of the sleep-wake cycle and can take an immense toll on daily life.
We Develop Innovative Medicines
Alkermes’ technologies and discoveries have contributed to the development of medicines that have helped shape the treatment landscape, and form the basis for our current investigational products, in a range of disease areas.
Proprietary U.S. Medicines
Our mission to make innovative medicines that may help address unmet patient needs underlies our work. Our portfolio of proprietary commercial products focuses on chronic, highly prevalent conditions that represent some of the most challenging health issues of our time.
Product Candidates in Development
Our research and development efforts are focused on the pursuit of potential new medicines that build on our heritage in neuroscience.
